Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Xellia Pharmaceuticals ApS

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 2,462,641 More Arrow 2,958,004 More Arrow 3,360,059
Earnings before taxes 1,499,054 Less Arrow -3,168,294 More Arrow -381,008
Total assets 4,927,906 Less Arrow 3,133,962 More Arrow 5,178,202
Current assets 2,149,836 Less Arrow 1,969,223 Less Arrow 1,602,580
Current liabilities 3,694,665 Less Arrow 3,042,051 Less Arrow 1,639,291
Equity capital 250,138 Less Arrow -889,977 More Arrow 2,619,856
- share capital 309,489 Less Arrow 299,252 More Arrow 300,793
Employees (average) 750 Less Arrow 350 Equal arrow 350

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 5.1% Less Arrow -28.4% More Arrow 50.6%
Turnover per employee 3,284 More Arrow 8,451 More Arrow 9,600
Profit as a percentage of turnover 60.9% Less Arrow -107.1% More Arrow -11.3%
Return on assets (ROA)
Current ratio 58.2% More Arrow 64.7% More Arrow 97.8%
Return on equity (ROE) 599.3% Less Arrow 356.0% Less Arrow -14.5%
Change turnover -596,550 More Arrow -384,840 More Arrow 677,424
Change turnover % -20% More Arrow -12% More Arrow 25%
Chg. No. of employees 400 Less Arrow 0 Equal arrow 0
Chg. No. of employees % 114% Less Arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.